# Progress Note 07 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Emily Dickinson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI023-SYN
- Date: 2026-10-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucinda Hartwell, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic preventive visit; no new complaints. **S**

## History of present illness

Ms. Dickinson is a 54-year-old woman with stage G3a A2 chronic kidney disease and hypertension who comes to the clinic for her periodic preventive visit, three weeks after her six-month kidney review by video. She chose a quiet first appointment of the morning and asked that her vaccines, cervical screening, and mammogram be done on this one trip; her second hepatitis B dose was held for today for the same reason. She completed the health risk assessment at home and sent it in beforehand. She has had no headaches for several months. She takes losartan 100 mg, dapagliflozin 10 mg, amlodipine 5 mg, atorvastatin 20 mg, and vitamin D3 daily, and she has taken no NSAIDs. She has had no illness since the gastroenteritis in April. Her home blood pressure averages 118/72. She writes most mornings and works in her garden most afternoons. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 54 |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Taken daily from a weekly organizer; sick-day card in her medicine cabinet; no NSAIDs or supplements other than vitamin D3 |
| Active conditions | Chronic kidney disease G3a A2 with albuminuria falling on treatment; hypertension at target; vitamin D deficiency treated |
| Functional status | Independent in all activities of daily living; writes full mornings and gardens most afternoons |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, better than at the start of the year |
| Psychosocial | Content at home; writes to a few close friends; feels well supported by her household; does not feel lonely |
| Tobacco | Never used tobacco |
| Alcohol and drugs | No alcohol (AUDIT-C 0); no other drug use |
| Physical activity | Garden work and walking in her garden about 160 minutes a week |
| Nutrition | Cooks at home with little added salt; plenty of vegetables and fruit from her garden |
| Sleep | About seven hours a night since the headaches stopped |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent; another household member drives and runs errands |
| Home safety | Smoke detectors working; no firearms in the home |
| Hearing and vision | Hears well; uses reading glasses; no eye examination for several years |
| Safety | Wears a seat belt; does not drive |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or fatigue |
| Eyes | Negative | No eye pain, redness, light sensitivity, or change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss or dental pain |
| Cardiovascular | Negative | No chest pain, palpitations, ankle swelling, or lightheadedness |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No nausea, change in bowel habit, or bleeding |
| Genitourinary | Negative | No urinary symptoms or genital infections on dapagliflozin; postmenopausal for three years with no bleeding |
| Musculoskeletal | Negative | No joint pain or muscle aches on atorvastatin |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | No headaches for several months; no numbness or weakness |
| Psychiatric | Negative | Mood good; PHQ-2 0 and GAD-7 3 |
| Breast | Negative | No lumps, pain, or nipple discharge |

12 systems reviewed. **S**

## Current medications

- Losartan 100 mg oral tablet, one tablet by mouth daily **S**
- Atorvastatin 20 mg oral tablet, one tablet by mouth daily **S**
- Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth daily **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a day **S**
- Dapagliflozin 10 mg oral tablet, one tablet by mouth daily **S**
- Amlodipine 5 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/74 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 53.5 kg; BMI 20.1 kg/m². All vital signs are synthetic.

PHQ-2: 0; GAD-7: 3; AUDIT-C: 0. All results are synthetic.

## Change since baseline

- GAD-7: 5 at baseline, 3 at this visit **S**

## Immunizations given today

- Hepatitis B vaccine, CpG-adjuvanted (HepB-CpG), dose 2 of 2 **S**
- Influenza vaccine, 2026-2027 season **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Slight, well woman; weight 53.5 kg, BMI 20.1 |
| Eyes | Pupils equal and reactive; undilated fundi show mild arteriolar narrowing without hemorrhages or exudates |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm at 70 per minute; no murmur; no edema |
| Respiratory | Clear |
| Breast | No masses, skin changes, or axillary nodes |
| Abdomen | Soft and non-tender; no masses or bruits |
| Pelvic | Normal external genitalia, vagina, and cervix; HPV sample collected |
| Skin | No suspicious lesions |
| Psychiatric | Calm and engaged; euthymic |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic preventive visit, age 54**. Health risk assessment reviewed and a written prevention plan given. Depression, anxiety, and alcohol screens are negative. She takes a statin for chronic kidney disease. HbA1c 5.5 percent in January. **S**
   - Next preventive visit in one year, booked again as a quiet first appointment.
2. **Chronic kidney disease G3a A2** (N18.31). eGFR 50 and urine albumin-creatinine ratio 96 mg/g three weeks ago, stable and improving on losartan and dapagliflozin. **S**
   - Continue current treatment; eGFR, urine albumin, hemoglobin, and KFRE in January.
3. **Hypertension with chronic kidney disease** (I12.9). 120/74 mmHg in the clinic and 118/72 at home, at target; mild arteriolar narrowing on fundoscopy. **S**
   - No change; a dilated eye examination as below.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 120/74 mmHg; treated hypertension at target |
| Cholesterol and statin | Up to date | Lipid panel in January; on atorvastatin for chronic kidney disease, without routine repeat testing |
| Diabetes screening | Up to date | HbA1c 5.5 percent in January; repeat in three years |
| Breast cancer screening | Ordered | No mammogram for four years because of the travel involved. Biennial screening from 40 to 74 discussed; a screening mammogram is booked at the imaging suite downstairs straight after this visit, so it needs no extra trip |
| Cervical cancer screening | Completed today | Primary HPV test collected today, about six years after her last screen; result by letter. If negative, repeat in five years |
| Colorectal cancer screening | Ordered | No prior screening. Options discussed; she chose a yearly fecal immunochemical test she can do at home, and a kit was given today. A positive test needs colonoscopy |
| Osteoporosis screening | Not indicated | Postmenopausal and under 65; FRAX ten-year major osteoporotic fracture risk 5.8 percent, below the threshold for bone density testing. Review yearly, given her low body weight and chronic kidney disease |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 3 in June |
| Anxiety screening | Completed today | GAD-7 score 3 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Hepatitis C and HIV screening | Up to date | Both negative five years ago; no new risk |
| Hepatitis B vaccine | Completed today | Dose 2 of HepB-CpG given today, completing the two-dose series begun in June |
| Influenza vaccine, this season | Completed today | Given today |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 in two to six months, which can be given at a home visit |
| Pneumococcal vaccine | Up to date | PCV20 in January; no further doses needed |
| COVID-19 vaccine, this season | Due | Recommended; she will have it at the zoster dose 2 home visit |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap seven years ago; next due in three years |
| Eye examination | Referred | Dilated eye examination for hypertension, which the CMID advises yearly; she had eye treatment for light sensitivity long ago and none recently. Booked with the optometrist in this building on the day of her next clinic trip |
| Dental examination | Due | No dental visit for two years; she will book one |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent from her household and completed a health care proxy form; the agent is recorded in the chart and is not named here. She said that what matters most to her is staying in her own home, keeping her privacy, and being able to write. She wants full treatment for reversible illness, with care at home whenever it is safe. She would not want dialysis started without a frank discussion of what it would mean for her daily life, and she asked for information about conservative kidney care for the future. She chose not to record other specific treatment preferences today. The plan will be revisited yearly and at any change in kidney function. **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, and depression monographs (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force

## Follow-up

- Mammogram straight after this visit. Return the stool test kit within two weeks. Zoster dose 2 and the COVID-19 vaccine at a home visit in two to six months. Yearly kidney tests and review in January. Next preventive visit in one year. **S**

